The FDA is aware of the issues arising from labels mentioning GLP-1 but has no future or intended action on the matter, said Kyle Diamantas, then deputy foods commissioner and now acting FDA commissioner, in a March 24 interview with Bloomberg Law
Terzepatide Terzepatide is a glucose-dependent insulinotropic polypeptide, a glucagon-like peptide-1 or GLP-1 and glucagon triple agonist
For individuals interested in the potential benefits associated with these peptides such as weight loss, improved body composition, or enhanced recovery there are safer, evidence-based alternatives available through NHS and private healthcare pathways
Research-grade cagrilintide from peptide suppliers varies significantly by vendor and may not match the pharmaceutical-grade material used in clinical trials
Supporting information S1 Table
MEDVis compounded options offer the same drug class at a fraction of that cost, with full medical oversight included